Smith Scott E 4
4 · ProUroCare Medical Inc. · Filed Feb 9, 2011
Insider Transaction Report
Form 4
Smith Scott E
Director
Transactions
- Award
Common Stock, $0.00001 par value
2011-02-08$1.01/sh+3,961$4,001→ 139,359 total
Holdings
- 20,000
Warrants
Exercise: $1.30From: 2009-11-12Exp: 2012-11-12→ Common stock, $0.00001 par value (20,000 underlying) - 30,000
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (30,000 underlying) - 14,535
Options
Exercise: $1.72Exp: 2017-08-10→ Common stock $0.00001 par value (14,535 underlying) - 10,000
Warrants
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (10,000 underlying) - 3,000
Stock Options
Exercise: $7.00Exp: 2013-05-30→ Common Stock, $0.00001 par value (3,000 underlying) - 7,000
Warrants
Exercise: $0.70Exp: 2012-12-31→ Common Stock, $0.00001 par value (7,000 underlying) - 1,000
Stock Options
Exercise: $1.00Exp: 2015-08-12→ Common stock, $0.00001 par value (1,000 underlying) - 20,000
Stock Options
Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (20,000 underlying) - 1,000
Stock Options
Exercise: $1.25Exp: 2016-08-11→ Common Stock, $0.00001 par value (1,000 underlying) - 32,475
Warrants
Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.00001 par value (32,475 underlying)
Footnotes (3)
- [F1]Currently exercisable.
- [F2]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
- [F3]Shares issued in lieu of cash for directors' fees as approved by the issuer's Board of Directors, which are exempt under Section 16b-3(d).